Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Rebecca Whittaker

How does Moderna’s new melanoma vaccine work – and could it treat other cancers?

A personalised vaccine given in combination with a drug has been shown to stop tumors returning in skin cancer patients.

The experimental mRNA cancer drug, called intismeran, which is personalised for each patient, was developed by pharmaceutical companies Merck & Co or MSD and Moderna.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.